Showing results (161-170 of 410) with videos related to
Sort By:
Pageof 41
The Journal of Biological Chemistry|November 18, 2006
Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125bGary K Scott, Andrei Goga, Dipa Bhaumik, et al.Hepato-Gastroenterology|January 10, 2001
The role of serum liver enzymes in the diagnosis of choledocholithiasisJ C Pereira-Limâ, R Jakobs, J V Busnello, et al.Gastrointestinal Endoscopy|May 26, 2001
Minilaparoscopy versus conventional laparoscopy in the diagnosis of hepatic diseasesA R Schneider, C Benz, H E Adamek, et al.Molecular and Cellular Endocrinology|February 18, 1999
Oxidant stress impaired DNA-binding of estrogen receptor from human breast cancerX Liang, B Lu, G K Scott, et al.The Journal of Biological Chemistry|August 5, 1994
Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cellsG K Scott, J C Daniel, X Xiong, et al.Hepato-Gastroenterology|January 30, 2002
Expression of apoptosis and apoptosis-related peptides in various stages of rejection in the human transplanted liverU Töx, M A Burkhardt, C Benz, et al.Journal of Cutaneous Pathology|June 1, 2019
Loss of ZNF750 in ocular and cutaneous sebaceous carcinomaJeffrey P North, David A Solomon, Justin Golovato, et al.Cancer Research|July 1, 1985
Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and responseC Benz, M DeGregorio, S Saks, et al.Biochemistry|July 29, 2000
Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA bindingR M Whittal, C C Benz, G Scott, et al.Breast Cancer Research and Treatment|February 25, 2014
mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanismsKathleen A Wilson-Edell, Mariya A Yevtushenko, Daniel E Rothschild, et al.Pageof 41